infographic
INFOGRAPHIC: Celebrating 21 Years of Discovery with Phospholamban Antibodies
Please rate these pages to support our infographic project.
Get free premium widgets for your blog and website.
About this infographic
The interactive infographic above captures advances made by the cardiac research community using Ser-16 & Thr-17 antibodies to phospholamban. Please click through to access further materials relating to Heart Failure and PLN Phosphorylation Signalling. Other themes are linked to associated research publications.
Your feedback is important
This work forms part of an undergraduate research project carried out at the University of Leeds in conjunction with our company, Badrilla Ltd., a specialist supplier of research tools for cardiovascular research. The success of this project will be measured by the level of audience engagement with our infographic and associated content.
How you can help
Please support our project by rating our content using the simple star system at the top of each web page. We thank you for participating in this research.
Undergraduate review articles
The following review articles have been written as supporting materials for this project:
- The Role of Phospholamban in Heart Failure by Lora Maxwell
- The Role of Phospho-ser-16-Phospholamban in Cardiac Physiology by Yael Lesin-Davis
Research themes
About us
Badrilla is a manufacturer of outstanding antibodies against cardiac proteins and phospho-proteins, and the manufacturer of leading kits for the study of protein S-palmitoylation.
Follow us on social
Contact us
We look forward to providing your favourite antibodies and kits
